von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 8584997)

Published in Thromb Haemost on August 01, 1995

Authors

A D Blann1, M Dobrotova, P Kubisz, C N McCollum

Author Affiliations

1: Department of Surgery, University Hospital of South Manchester, UK.

Articles by these authors

(truncated to the top 100)

Sustained compression and healing of chronic venous ulcers. BMJ (1988) 4.30

Pressure sores. BMJ (1994) 4.04

Community clinics for leg ulcers and impact on healing. BMJ (1992) 3.28

Evaluation of the HemoCue for measuring intra-operative haemoglobin concentrations: a comparison with the Coulter Max-M. Anaesthesia (1998) 1.80

Ultrasound measurement of aortic diameter in a national screening programme. Eur J Vasc Endovasc Surg (2011) 1.68

von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens (1993) 1.63

Screening for abdominal aortic aneurysm: a computer assisted cost-utility analysis. Eur J Vasc Endovasc Surg (1996) 1.61

Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. BMJ (1989) 1.60

Controlled trial of occlusive dressings in healing chronic venous ulcers. Br J Surg (1987) 1.57

Does 111indium-platelet deposition predict patency in prosthetic arterial grafts? Br J Surg (1983) 1.55

Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals. Blood Coagul Fibrinolysis (2002) 1.50

Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg (1994) 1.48

Early carotid surgery in acute stroke: a multicentre randomised pilot study. Cerebrovasc Dis (2004) 1.43

What are the risk factors for renal failure following open elective abdominal aortic aneurysm repair? Eur J Vasc Endovasc Surg (2011) 1.41

Calcium alginate as haemostatic swabs in hip fracture surgery. J R Coll Surg Edinb (1997) 1.39

Delayed carotid surgery: what are the causes in the north west of England? Eur J Vasc Endovasc Surg (2012) 1.38

Cerebral injury during cardiopulmonary bypass: emboli impair memory. J Thorac Cardiovasc Surg (2001) 1.31

Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers. J Pathol (2000) 1.17

Factors associated with healing leg ulceration with high compression. Age Ageing (1995) 1.15

Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg (1986) 1.14

Carotid disease in acute stroke. Age Ageing (1998) 1.09

Cerebral oximetry in patients undergoing carotid endarterectomy under regional anesthesia. Stroke (1996) 1.08

Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey. BMJ (2003) 1.06

Adverse influence of cigarette smoking on the endothelium. Thromb Haemost (1993) 1.04

Venous disease is associated with an impaired range of ankle movement. Eur J Vasc Endovasc Surg (2003) 1.04

Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol (1992) 1.02

Association of nucleoplasmin with transcription products as revealed by immunolocalization in the amphibian oocyte. J Cell Biol (1986) 1.01

Particulate contaminants of intravenous medications and infusions. J Pharm Pharmacol (1987) 1.01

Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions. J Invest Dermatol (1996) 1.01

Evaluating the cost and efficacy of leg ulcer care provided in two large UK health authorities. J Wound Care (2002) 1.01

von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg (1994) 1.00

The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis (1998) 0.99

Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens (1994) 0.99

Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer. Br J Cancer (2008) 0.98

Prevalence of venous disease: a community study in west London. Eur J Surg (1992) 0.97

Final inline filtration for intravenous infusions: a prospective hospital study. Br J Surg (1983) 0.97

Pilot study of carotid surgery for acute stroke. Br J Surg (1997) 0.96

Monitoring wound healing by odour. J Wound Care (1997) 0.96

Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs. Surgery (1980) 0.95

Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost (1997) 0.95

Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost (1994) 0.95

Leg ulcer odour detection identifies beta-haemolytic streptococcal infection. J Wound Care (1995) 0.95

Carotid endarterectomy improves cognitive function in patients with exhausted cerebrovascular reserve. Eur J Vasc Endovasc Surg (2003) 0.94

The contribution of the external carotid artery to cerebral perfusion in carotid disease. J Vasc Surg (2000) 0.93

A questionnaire to assess risk factors, quality of life, and use of health resources in patients with venous disease. Eur J Surg (1992) 0.92

Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease. Br J Haematol (1996) 0.91

Cerebral embolisation during modern cardiopulmonary bypass. Eur J Cardiothorac Surg (2001) 0.91

Femoropopliteal bypass grafts--an isotope technique allowing in vivo comparison of thrombogenicity. Br J Surg (1982) 0.90

Preoperative cardiopulmonary exercise testing and risk of early mortality following abdominal aortic aneurysm repair. Br J Surg (2012) 0.89

Rheological properties and function of blood cells in stored bank blood and salvaged blood. Br J Haematol (1998) 0.89

Arterial graft maturation: the duration of thrombotic activity in Dacron aortobifemoral grafts measured by platelet and fibrinogen kinetics. Br J Surg (1981) 0.89

Light-reflective cerebral oximetry and jugular bulb venous oxygen saturation during carotid endarterectomy. Br J Surg (1994) 0.88

Increased soluble P-selectin following myocardial infarction: a new marker for the progression of atherosclerosis. Blood Coagul Fibrinolysis (1997) 0.88

National risk prediction model for elective abdominal aortic aneurysm repair. Br J Surg (2013) 0.88

Prevention of venous thromboembolism in surgical patients with breast cancer. Br J Surg (2007) 0.87

Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor. Inflammation (1998) 0.87

Iliac artery aneurysm simulating nerve root compression. J R Coll Surg Edinb (1983) 0.87

The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices. Thromb Haemost (1997) 0.87

Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest (1997) 0.87

Should heparin be reversed after carotid endarterectomy? A randomised prospective trial. Eur J Vasc Endovasc Surg (1997) 0.87

New data on Glanzmann's thrombasthenia. Proc Soc Exp Biol Med (1971) 0.87

Expression of cyclooxygenase isoforms in normal human skin and chronic venous ulcers. J Pathol (2001) 0.86

Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man. Ann Surg (1983) 0.85

[Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis]. Vnitr Lek (2004) 0.84

Evaluation of five risk prediction models for elective abdominal aortic aneurysm repair using the UK National Vascular Database. Br J Surg (2012) 0.84

Alteration in platelet function in patients with early breast cancer. Anticancer Res (2005) 0.84

Oxerutins in the prevention of recurrence in chronic venous ulceration: randomized controlled trial. Br J Surg (1991) 0.84

Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease. Eur J Haematol (1997) 0.84

Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb Haemost (1998) 0.84

Circulating adhesion molecules in inflammatory and atherosclerotic vascular disease. Immunol Today (1995) 0.83

Approaches to venous leg ulcer care within the community: compression, pinch skin grafts and simple venous surgery. Ostomy Wound Manage (1996) 0.83

Shortening and reimplantation for tortuous internal carotid arteries. J Vasc Surg (1998) 0.83

Recent developments in cerebral monitoring--near-infrared light spectroscopy. An overview. Eur J Vasc Endovasc Surg (1996) 0.83

The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res (1997) 0.83

Platelet accumulation on mature Dacron grafts in man. Br J Surg (1982) 0.82

Comparison of absorbable materials for surgical haemostasis. Br J Surg (1988) 0.82

Changes in von Willebrand factor and soluble ICAM, but not soluble VCAM, soluble E selectin or soluble thrombomodulin, reflect the natural history of the progression of atherosclerosis. Atherosclerosis (2002) 0.82

Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls. Atherosclerosis (2000) 0.82

[Successful treatment of hemothorax with recombinant factor VIIa in a hemophilic child with inhibitor]. Vnitr Lek (1998) 0.82

Soluble adhesion molecules, endothelial markers and atherosclerosis risk factors in abdominal aortic aneurysm: a comparison with claudicants and healthy controls. Blood Coagul Fibrinolysis (1998) 0.82

Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis. Eur J Vasc Endovasc Surg (1996) 0.81

von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis. Coron Artery Dis (1996) 0.81

Pulsed electromagnetic energy fails to prevent postoperative ileus. J R Coll Surg Edinb (1984) 0.81

Lower limb ischaemia and reperfusion alters gut permeability. Eur J Vasc Surg (1992) 0.81

More on: thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control study. J Thromb Haemost (2005) 0.81

Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication. Thromb Haemost (1997) 0.81

Cerebral hypoxia detected by near infrared spectroscopy. Anaesthesia (1994) 0.80

The influence of homologous blood transfusion on immunity and clinical outcome in aortic surgery. Eur J Vasc Endovasc Surg (2001) 0.80

von Willebrand factor, the endothelium and obesity. Int J Obes Relat Metab Disord (1993) 0.80

Unchanging attitudes to autologous transfusion in the UK. Transfus Med (2001) 0.80

Effect of superficial venous surgery on venous function in chronic venous insufficiency. Ann Vasc Surg (2005) 0.80

Cerebral oxygen saturation, transcranial Doppler ultrasonography and stump pressure in carotid surgery. Br J Surg (1994) 0.79

Opsonic dysfunction secondary to plasma fibronectin depletion after aortic surgery. Br J Surg (1986) 0.79

Platelet aggregation induced by soluble fibrin monomer complexes. Life Sci II (1970) 0.79

[Factor V Leiden and the Slovak population]. Vnitr Lek (2003) 0.79

Increased soluble P-selectin in peripheral artery disease: a new marker for the progression of atherosclerosis. Thromb Haemost (1998) 0.79

Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease. Thromb Res (2000) 0.79

Current UK practice of thromboprophylaxis for breast surgery. Br J Surg (2006) 0.78

Trigger-fired pinch-graft harvester for use in chronic venous ulcers. Br J Surg (1997) 0.78

Career choices in 21st-century healthcare: Aiming for a moving target. Int J Surg (2008) 0.78